{
    "clinical_study": {
        "@rank": "99163", 
        "arm_group": [
            {
                "arm_group_label": "Normal renal function"
            }, 
            {
                "arm_group_label": "Stage 2 and 4 and 5 chronic kidney disease"
            }, 
            {
                "arm_group_label": "End stage renal disease on hemodialysis"
            }
        ], 
        "brief_summary": {
            "textblock": "The value of HbA1c as a tool to determine glycemic control in patients with diabetes and\n      renal failure has not been well studied, the same accepted normal ranges for HbA1c are\n      applied to all patients with diabetes regardless of their renal function. We would like to\n      evaluate the use of HbA1c as a tool of assessing long term glycemic control in this subgroup\n      of patients with diabetes and evaluate the effect of dialysis on HbA1c"
        }, 
        "brief_title": "The Correlation Between HbA1c and Mean Blood Glucose in Patients With Diabetes and Renal Failure", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Diabetes", 
            "Renal Failure"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Renal Insufficiency"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        All patients >18 years of age with type 1 or 2 diabetes who show competence in home\n        glucose monitoring and are willing to commit to doing the testing\n\n        Exclusion Criteria:\n\n          -  Pregnancy\n\n          -  Having received a blood transfusion with in the preceding three months\n\n          -  Known to have any hereditary or hemolytic anemia\n\n          -  On a medication known to interfere with HbA1c assay (opiates, acetaminophen, vitamin\n             C, vitamin E) - we will allow patients to be on asprin as almost all patients with\n             diabetes are on this drug.\n\n          -  Having a blood hemoglobin <7 mg/dl\n\n          -  Bilirubin level >20mg/dL or a triglyceride level > 250mg/dL\n\n          -  Alcohol addiction"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Our target population is patients with diabetes and impaired renal function. This study\n        will include 80 adult patients with type1 or type 2 diabetes; 20 with normal serum\n        creatinine, 40 with renal failure in the predialysis stage (20 with stage 3 and 4 CKD [GFR\n        0f 20-40] and 20 with stage 5 CKD not yet on hemodialysis [GFR <20]), and 20 on\n        hemodialysis. All patients should be comfortable and committed to doing self-glucose\n        monitoring."
            }
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01937858", 
            "org_study_id": "RC08/107/A"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "HbA1c", 
            "glycated hemoglobin", 
            "correlation", 
            "diabetes", 
            "renal failure"
        ], 
        "lastchanged_date": "September 4, 2013", 
        "location": {
            "contact": {
                "email": "OraibiS@NGHA.MED.SA", 
                "last_name": "Suzan Aloraibi", 
                "phone": "+966-13-5910000", 
                "phone_ext": "36289"
            }, 
            "contact_backup": {
                "email": "amoudir@ngha.med.sa", 
                "last_name": "Reem Alamoudi", 
                "phone": "+966-13-8581111", 
                "phone_ext": "31504"
            }, 
            "facility": {
                "address": {
                    "city": "Al-Ahsa", 
                    "country": "Saudi Arabia", 
                    "zip": "31982"
                }, 
                "name": "King Abdulaziz National Guards Hospital"
            }, 
            "investigator": {
                "last_name": "Reem M Alamoudi", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Saudi Arabia"
        }, 
        "number_of_groups": "3", 
        "official_title": "The Correlation Between HbA1c and Mean Blood Glucose in Patients With Diabetes and Renal Failure", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Saudi Arabia: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The quantitative correlation between mean blood glucose and HbA1c in patients with diabetes and renal failure", 
            "measure": "Correlation", 
            "safety_issue": "No", 
            "time_frame": "three months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01937858"
        }, 
        "responsible_party": {
            "investigator_affiliation": "King Abdullah International Medical Research Center", 
            "investigator_full_name": "Reem Mohammad Alamoudi", 
            "investigator_title": "Consultant Endocrinology", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "King Abdullah International Medical Research Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Reem Mohammad Alamoudi", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "September 2013"
    }
}